F2G Plans Orphan Drug Strategy With Novel Antifungal

 
• By Joseph Haas
  
Superbug strain bacteria concept as a killer microbe shaped as a death skull face as a symbol for MRSA medical healthcare risk and antimicrobial health hazard as a 3D illustration on white. - Illustration
F2G thinks its novel antifungal can benefit patients who've run out of therapeutic options

More from Clinical Trials

More from R&D